Preoperative multimodal strategies for risk assessment of adnexal masses analysis of 1362 cases in a gynecologic cancer center

International Journal of Gynecological Cancer

Volumn 21, Issue 6, 2011, Pages 1056-1062

  Radosa, Marc Philipp ^a   Camara, Oumar ^a   Vorwergk, Julia ^a   Diebolder, Herbert ^a   Winzer, Harald ^a   Mothes, Anke ^a   Gajda, Mieczyslaw ^a   Runnebaum, Ingo Bernard ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Adnexal lesions; CA 125; Expert sonography; Menopausal state; Preoperative differentiation; RMI; Triage strategies

Indexed keywords

CA 125 ANTIGEN;

ADNEXA DISEASE; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; CLINICAL ASSESSMENT TOOL; COLPOSCOPY; DIAGNOSTIC TEST; FALSE POSITIVE RESULT; FEMALE; GYNECOLOGICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MALIGNANCY INDEX; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; TRANSVAGINAL ECHOGRAPHY; TUMOR DIFFERENTIATION;

ADNEXAL DISEASES; ADULT; CA-125 ANTIGEN; COMBINED MODALITY THERAPY; FEMALE; GERMANY; HUMANS; LAPAROSCOPY; MIDDLE AGED; NEOPLASM STAGING; OUTPATIENT CLINICS, HOSPITAL; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRIAGE;

EID: 83055165662     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182187eb0     Document Type: Article

References (26)

1. Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97:922Y929. (Pubitemid 20340625)
2. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213Y220.
3. Sokalska A, Timmerman D, Testa AC, et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol. 2009;34:462Y470.
4. Valentin L. Pattern recognition of pelvic masses by gray-scale ultrasound imaging: the contribution of Doppler ultrasound. Ultrasound Obstet Gynaecol. 1999;14:338Y347. (Pubitemid 30032358)
5. Van den Akker PA, Aalders AL, Snijders MP, et al. Evaluation of the risk of malignancy index in daily clinical management of adnexal masses. Gynecol Oncol. 2010;116:384Y388.
6. Timmerman D, Van Calster B, Testa AC, et al. Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynaecol. 2010;36:226Y234.
7. Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynaecol. 1999;93:448Y452. (Pubitemid 29107011)
8. Yamamoto Y, Yamada R, Oguri H, et al. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Eur J Obstet Gynaecol Reprod Biol. 2009;144:163Y167.
9. Colomer AT, Jiménez AM, Bover Barceló MI. Laparoscopic treatment and staging of early ovarian cancer. J Minim Invasive Gynecol. 2008;15:414Y419. (Pubitemid 351888957)
10. Cadron I, Leunen K, Van Gorp T, et al. Management of borderline ovarian neoplasms. J Clin Oncol. 2007;25: 2928Y2937. (Pubitemid 47123157)
11. Klug TL, Bast RC Jr, Niloff JM, et al. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res. 1984;44:1048Y1053. (Pubitemid 14152791)
12. Van Holsbeke C, Daemen A, Yazbek J, et al. Ultrasound methods to distinguish between malignant and benign adnexal masses in the hands of examiners with different levels of experience. Ultrasound Obstet Gynecol. 2009;34:454Y461.
13. Vorgias G, Iavazzo C, Savvopoulos P, et al. Can the preoperative CA-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma. A single institution cohort study. Gynecol Oncol. 2009;112:11Y15.
14. Vogl FD, Frey M, Kreienberg R, et al. Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer. 2000;83:1338Y1343.
15. Berlanda N, Ferrari MM, Mezzopane R, et al. Impact of a multiparameter, ultrasound-based triage on surgical management of adnexal masses. Ultrasound Obstet Gynaecol. 2002;20:181Y185. (Pubitemid 35300716)
16. Guerriero S, Alcazar JL, Pascual MA, et al. Intraobserver and interobserver agreement of grayscale typical ultrasonographic patterns for the diagnosis of ovarian cancer. Ultrasound Med Biol. 2008;34:1711Y1716.
17. Yazbek J, Raju KS, Ben-Nagi J, et al. Accuracy of ultrasound subjective 'pattern recognition' for the diagnosis of borderline ovarian tumors. Ultrasound Obstet Gynaecol. 2007;29:489Y495. (Pubitemid 46826548)
18. Van Calster B, Timmerman D, Bourne T, et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst. 2007;99:1706Y1714. (Pubitemid 351767215)
19. Van Holsbeke C, Daemen A, Yazbek J, et al. Ultrasound experience substantially impacts on diagnostic performance and confidence when adnexal masses are classified using pattern recognition. Gynecol Obstet Invest. 2010;69:160Y168.
20. van den Akker PA, Kluivers KB, Massuger LF. Letter to the editor concerning ''Increasing the effectiveness of referral of ovarian masses from cancer unit to cancer center by using a higher referral value of the risk of malignancy index.'' Int J Gynecol Cancer. 2010;20:552Y554.
21. Raza A, Mould T, Wilson M, et al. Increasing the effectiveness of referral of ovarian masses from cancer unit to cancer center by using a higher referral value of the risk of malignancy index. Int J Gynecol Cancer. 2010;20: 552Y554.
22. van den Akker PA, Aalders AL, Snijders MP, et al. Evaluation of the risk of malignancy index in fsdaily clinical management of adnexal masses. Gynecol Oncol. 2010;116: 384Y388.
23. van Trappen PO, Rufford BD, Mills TD, et al. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy. Int J Gynecol Cancer. 2007;17:61Y67. (Pubitemid 46213971)
24. Bailey J, Tailor A, Naik R, et al. Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases? Int J Gynecol Cancer. 2006; 16:30Y34.
25. Chilla B, Hauser N, Singer G, et al. Indeterminate adnexal masses at ultrasound: effect of MRI imaging findings on diagnostic thinking and therapeutic decisions. Eur Radiol. 2010. (Epub ahead of print). PMID:2117497.
26. Medeiros LR, Freitas LB, Rosa DD, et al. Accuracy of magnetic resonance imaging in ovarian tumor: a systematic quantitative review. Am J Obstet Gynecol. 2011;204:67.e1Ye10.